fintopic.
Docs Get the API

Sofinnova Partners launches €725M crossover fund

3 statements from 3 sources on Nov 16, 2026, 07:00–07:00 UTC
News
Updated
Front page

Statements (3)

  1. Neutral

    Sofinnova Partners closed a second crossover fund at €725 million for late-stage European biotechs

    endpoints.news
  2. Neutral

    Sofinnova Partners is launching a €725M 'crossover' fund to support later-stage biotechs.

    biopharmadive.com
  3. Neutral

    Sofinnova Partners closed a €725 million crossover II fund

    businesswire.com